Alvion Pharmaceuticals
PrivateLast Round
Strategic
Apr 1, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alvion Pharmaceuticals operates in Healthcare & Life Sciences and is based in Athens. Its latest recorded funding round was a Strategic round in April 2026.
Alvion Pharmaceuticals is a pharmaceutical company that develops and manufactures complex generic and value-added medicines for global markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alvion Pharmaceuticals Comparables
Compare Alvion Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adalvo | 85% | |
| Coripharma | 85% | |
| V-Ensure Pharma Technologies | 80% |
For institutional investors. Book with your work email.
Alvion Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alvion Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iGrow Venture Partners | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 231% MoM, reaching 1.8K.
- May 5, 2026
Grew 29% QoQ, from 17 to 22 employees.
For institutional investors. Book with your work email.
Alvion Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alvion Pharmaceuticals's valuation, stock price, and market status.
Is Alvion Pharmaceuticals a public or private company?
Alvion Pharmaceuticals is a private company.
What is the current stock price of Alvion Pharmaceuticals?
Alvion Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Alvion Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alvion Pharmaceuticals worth (valuation)?
Valuation information for Alvion Pharmaceuticals is not publicly available.
Can I buy Alvion Pharmaceuticals stock?
Alvion Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alvion Pharmaceuticals's last funding round?
Alvion Pharmaceuticals's most recent funding round was Strategic on April 1, 2026.
Who are the main investors in Alvion Pharmaceuticals?
Key investors in Alvion Pharmaceuticals include iGrow Venture Partners.
Will Alvion Pharmaceuticals IPO soon?
No public IPO plans have been announced for Alvion Pharmaceuticals.
How can I track Alvion Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Alvion Pharmaceuticals's shares on secondary markets.